Academic Journal
Q1European Urology Focus
About European Urology Focus
About European Urology Focus
European Urology Focus is a peer-reviewed scholarly journal published by Elsevier B.V. (Netherlands). It focuses on Q1. Publication coverage spans 2015-2026.
Key indicators: ISSN 2405-4569; H-index 67.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (67): Strong citation impact — 67 articles cited at least 67 times each, reflecting solid influence.
Publishing in European Urology Focus
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of European Urology Focus?
2405-4569.
Who publishes European Urology Focus?
Elsevier B.V..
What are European Urology Focus's metrics?
H-index 67.
Is European Urology Focus peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Prostate Cancer Diagnosis and Treatment; Bladder and Urothelial Cancer Treatments; Prostate Cancer Treatment and Research; Urinary Bladder and Prostate Research; Renal cell carcinoma treatment; Pelvic floor disorders treatments.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,800.00 USD; 3,550.00 EUR; 3,040.00 GBP; 471,310.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Contemporary Oncological and Patient-reported Outcomes of Intravesical Gemcitabine/Docetaxel in BCG-unresponsive Non–muscle-invasive Bladder Cancer: A Multi-institutional Prospective Cohort Study
Yu Guang Tan, J. Dudinec, A.M. Kamat, B.J.H. Lim et al.
2026-10 · DOI: 10.1016/j.euf.2026.09.008First-in-clinical Evaluation of Dual Contrast-enhanced Ultrasound-guided PCNL: A Multicenter Randomized Trial Versus Fluoroscopy
Donglai Shen, Shoupeng Li, Zhi Li, Haomin Liang et al.
2026-10 · DOI: 10.1016/j.euf.2026.09.003Re: Marie Semmler, Julian Marcon, Elena K. Berg, et al. Radical Prostatectomy Without Prior Biopsy? Final Histopathology of Radical Prostatectomies in 103 Consecutive Biopsy-naïve Patients Who Underwent Radical Prostatectomy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2026.06.030
Ilias Giannakodimos, Zisis Kratiras, Michael Chrisofos
2026-09 · DOI: 10.1016/j.euf.2026.08.014From Crisis to Innovation: The Impact of COVID-19 on Outpatient Procedures in Robotic Urological Surgery
Simone Crivellaro, Flavia Tamborino
2026-09 · DOI: 10.1016/j.euf.2025.06.015Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment
Benedikt Hoeh, Giovanni Mazzucato, Pierre Tennstedt, Jonas Ekrutt et al.
2026-09 · DOI: 10.1016/j.euf.2026.05.002Kidney-sparing Treatments for Local Recurrence in Renal Cell Tumours After Partial Nephrectomy or Focal Therapy: A Systematic Review
Francesco Di Bello, Andrea Gallioli, Alessandro Uleri, Gernot Ortner et al.
2026-09 · DOI: 10.1016/j.euf.2025.12.003Screening for Asymptomatic Bacteriuria Before Cystoscopy: A Systematic Review and Meta-analysis
Patrick G. Rice, Robyn S.E. Hawkins, Bhaskar K. Somani
2026-09 · DOI: 10.1016/j.euf.2026.07.016Re: Alec Zhu, Mary O. Strasser, Timothy D. McClure, et al. Comparative Effectiveness of Partial Gland Cryoablation Versus Robotic Radical Prostatectomy for Cancer Control. Eur Urol Focus 2024;10:843–50
Francesco Montorsi, Armando Stabile, Giorgio Gandaglia, Alberto Briganti et al.
2026-09 · DOI: 10.1016/j.euf.2025.06.022Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis
Tessa van Elst, Pedro Lopez, Laurien M. Buffart, Jose A.E. Custers et al.
2026-09 · DOI: 10.1016/j.euf.2025.12.001Self-management of Male LUTS
Farnoosh Nik-Ahd, Mohammad Albarqouni, Scott R. Bauer, Loai Albarqouni et al.
2026-09 · DOI: 10.1016/j.euf.2026.06.021Bacillus Calmette-Guérin–exposed Non–muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial Design
Seyed Behzad Jazayeri, Renzo G. DiNatale, Christopher Guske, Christian Harrs et al.
2026-09 · DOI: 10.1016/j.euf.2025.12.013Control of Confounding and Claims of Causality in Observational Studies of Neuraxial Anesthesia and Recurrence in Urologic Cancer: A Systematic Review
Lucia Salerno, Riccardo Leni, Amy L. Tin, Joshua S. Mincer et al.
2026-09 · DOI: 10.1016/j.euf.2025.11.003Re: Marie Semmler, Julian Marcon, Elena K. Berg, et al. Radical Prostatectomy Without Prior Biopsy? Final Histopathology of Radical Prostatectomies in 103 Consecutive Biopsy-naïve Patients Who Underwent Radical Prostatectomy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2026.06.030
Giulia Giannini, Isabel Heidegger
2026-09 · DOI: 10.1016/j.euf.2026.08.013Reply to Jens Borgbjerg, Ole Graumann, and David Breen's’s Letter to the Editor re: Ailbhe Lawlor, Mieke Van Hemelrijck, Charlotte Moss, et al. A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS). Eur Urol Focus. In press. http://dx.doi.org/10.1016/j.euf.2026.06.017
Ailbhe Lawlor, Saeed Dabestani, Lorenzo Marconi, Axel Bex et al.
2026-09 · DOI: 10.1016/j.euf.2026.08.009Should We Send TURP Histology for Pathological Examination?
Heikki Seikkula, Henrikki Santti, Marita Laurila, Kari A.O. Tikkinen et al.
2026-09 · DOI: 10.1016/j.euf.2026.07.020ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapy
Andrew L. Laccetti, Matthew R. Smith, Howard I. Scher, Sepehr Nowfar et al.
2026-09 · DOI: 10.1016/j.euf.2026.02.005Contemporary Trends in Primary Retroperitoneal Lymph Node Dissection in Nonseminomatous Germ Cell Tumors
Nick J. Lee, Federico Polverino, Leonardo Quarta, Maximilian Filzmayer et al.
2026-09 · DOI: 10.1016/j.euf.2026.08.010PSA Assessment in Male LUTS/BPE – CON
François Hervé
2026-09 · DOI: 10.1016/j.euf.2026.03.008Perioperative Management of Direct Oral Anticoagulants in Urological Surgery: The Prospective PAUSE-URO Study
Nicolas Carl, Eva Halber, Carl-Erik Dempfle, Dominik Loeschner et al.
2026-09 · DOI: 10.1016/j.euf.2026.08.008Conceptualizing the “High” Bladder Neck – Anatomic Rabbit Hole or Functional Gold Mine?
Melissa R. Kaufman, Hector S. Barba, Marcus J. Drake
2026-09 · DOI: 10.1016/j.euf.2026.07.017Reviews
Community Reviews
Version History
October 9, 2026 at 7:03 pm
September 25, 2026